Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,399.00
+25.40 (1.85%)
Oct 1, 2026, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 143.75 billion as of October 2, 2026. Its market cap has decreased by -16.60% in one year.
Market Cap
143.75B
Enterprise Value
139.44B
Revenue
11.08B
Ranking
n/a
PE Ratio
52.37
Stock Price
1,399.00
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 143.75B, an increase of 45.75%. That is a compound annual growth rate of 12.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 143.75B | 2.12% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 603.61B |
| Anthem Biosciences | 481.95B |
| OneSource Specialty Pharma | 172.89B |
| Blue Jet Healthcare | 102.55B |
| Supriya Lifescience | 74.93B |
| Zota Health Care | 43.91B |
| Dishman Carbogen Amcis | 23.57B |
| Panacea Biotec | 21.99B |